Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to -$2.1 million.

  • Anika Therapeutics' Other Working Capital Changes fell 198.65% to -$219,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 41.36%. This contributed to the annual value of -$2.1 million for FY2024, which is 3.12% up from last year.
  • As of FY2024, Anika Therapeutics' Other Working Capital Changes stood at -$2.1 million, which was up 3.12% from -$2.1 million recorded in FY2023.
  • Over the past 5 years, Anika Therapeutics' Other Working Capital Changes peaked at $1.8 million during FY2020, and registered a low of -$2.1 million during FY2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$2.1 million (2024), whereas its average is -$1.9 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 191.19% in 2021, then climbed by 8.67% in 2022.
  • Yearly analysis of 5 years shows Anika Therapeutics' Other Working Capital Changes stood at $1.8 million in 2020, then crashed by 191.19% to -$1.6 million in 2021, then rose by 8.67% to -$1.5 million in 2022, then crashed by 44.71% to -$2.1 million in 2023, then increased by 3.12% to -$2.1 million in 2024.